⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Humana earnings beat estimates as medical costs jump by less-than-expected

Published 08/02/2023, 07:13 AM

Investing.com -- Health insurance group Humana (NYSE:HUM) reported a bump in second-quarter medical costs that was lower than anticipated despite strong demand for surgeries following the COVID-19 pandemic, boosting profit above estimates.

Humana, along with peer UnitedHealth (NYSE:UNH), warned in June that medical expenses would jump in 2023 as more patients go ahead with elective procedures that had been delayed by the pandemic. Staffing shortages and health restrictions meant that many surgeries, particularly those on older adults at greater risk of contracting severe COVID-19, were previously put on hold.

Analysts have also noted that aging in the so-called "baby boomer" generation -- the cohort born from 1946 to 1964 - as well as elevated life expectancies are adding pressure on health insurers' returns.

Humana's benefit expense ratio - a gauge of how much premium dollars the company's health plans spend on medical claims - grew to 86.3% in the second quarter, but was still below Bloomberg consensus estimates of 86.8%. The figure stood at 85.8% in the corresponding three-month period in 2022.

Quarterly adjusted earnings per share rose to $8.94, topping forecasts for profit per share of $8.83.

Shares in Humana increased by more than 2% in premarket U.S. trading following the results.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.